🔗 Share this article

Chancellor Reeves has revealed she is planning "focused action to deal with household expense pressures" in next month's Budget.

In comments to the BBC, she emphasized that reducing price rises is a collective responsibility of both the administration and the central bank.

The United Kingdom's price growth is expected to be the most elevated among the Group of Seven advanced economies this calendar year and next.

Potential Utility Bill Interventions

Reports indicate the government could take action to reduce utility costs, for example by cutting the current 5% level of VAT charged on energy supplies.

Another option is to cut some of the policy costs currently added to bills.

Fiscal Constraints and Expert Predictions

The government will receive the next report from the official forecaster, the OBR, on Monday, which will clarify how much room there is for these measures.

The expectation from the majority of experts is that the Chancellor will have to declare tax rises or spending cuts in order to meet her voluntary borrowing rules.

Earlier on the same day, calculations suggested there was a twenty-two billion pound gap for the chancellor to resolve, which is at the more modest range of expectations.

"There's a shared responsibility between the Bank of England and the government to continue tackling some of the causes of price increases," Reeves told reporters in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.

Tax Pledges and Global Concerns

While much of the focus has been on likely tax increases, the Treasury chief said the latest information from the fiscal watchdog had not altered her pledge to manifesto promises not to increase tax levels on earnings tax, VAT or National Insurance.

She attributed an "unpredictable global environment" with increasing geopolitical and commercial issues for the fiscal revenue measures, likely to be directed on those "with the broadest shoulders."

Global Trade Tensions

Addressing apprehensions about the UK's economic relations with the Asian nation she said: "The UK's national security invariably are paramount."

Recent announcement by China to strengthen export controls on critical minerals and other materials that are essential for high-technology manufacturing led American leader Donald Trump to threaten an further 100% tariff on goods from China, raising the possibility of an full-scale trade war between the two economic giants.

The American finance chief called China's action "economic coercion" and "a international production power grab."

Questioned on accepting the American proposal to join its dispute with China, Reeves said she was "deeply worried" by Chinese measures and called on the Beijing authorities "to avoid restrictions and restrict access."

She said the action was "bad for the international commerce and causes additional headwinds."

"I believe there are areas where we must address Chinese policies, but there are also valuable prospects to trade with Chinese markets, including banking sector and other areas of the economy. We've got to maintain that equilibrium appropriate."

The Treasury chief also confirmed she was collaborating with international partners "on our own essential resources approach, so that we are reduced dependence."

NHS Medicine Costs and Funding

Reeves also recognized that the price the NHS spends on pharmaceuticals could increase as a result of ongoing negotiations with the US government and its drugs companies, in exchange for reduced taxes and investment.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either pausing or scrapping operations in the UK, with some attributing the low prices they are receiving.

Recently, the Science Minister said the price the health service spends on medicines would need to rise to prevent firms and pharmaceutical investment departing from the UK.

Reeves stated to media: "We have seen as a result of the payment system, that drug testing, innovative medicines have not been available in the United Kingdom in the manner that they are in other European countries."

"Our aim is to make sure that people getting treatment from the NHS are able to access the finest life-saving drugs in the world. And so we are looking at all of that, and... seeking to attract additional investment into Britain."